Comparison of below-knee and above-knee amputations with demographic, comorbidity, and haematological parameters in patients who died
Tóm tắt
This study aimed to establish mortality predictive parameters with a higher contribution to mortality by comparing the demographic data, comorbid factors, and haematological values of patients who underwent below-knee and above-knee amputation and had died during the follow-up period. Between March 2014 and January 2022, 122 patients in a single centre who developed foot gangrene due to chronic diabetes and underwent below-knee or above-knee amputation were evaluated retrospectively. Patients who died of natural causes during the post-operative period were included in the study. Those who were amputated below the knee were assigned to Group 1, and those who were amputated above the knee were assigned to Group 2. The patients’ age, gender, side of amputation, comorbid diseases, American Society of Anaesthesiologists (ASA) score, Charlson comorbidity index (CCI), death time, and haematological values at the time of first admission were compared between the two groups and statistical analyses were performed. Group 1 (n = 50) and Group 2 (n = 37) had similar distributions in terms of age, gender, side of operation, number of comorbidities, and CCI (p > 0.05). Group 2’s mean ASA score and c-reactive protein (CRP) levels were statistically higher than those of Group 1 (p < 0.05). Death time, albumin value, and HbA1c levels were statistically lower in Group 2 than in Group 1 (p < 0.05). There were no significant differences between the groups in haemogram, white blood cells (WBC), lymphocytes, neutrophils, creatinine, and Na values at the time of first admission (p > 0.05). A high ASA score, low albumin value, and high CRP value were significant predictors of high mortality. Creatinine levels and HbA1c values were quite ineffective in predicting mortality. Level 3, retrospective comparative study.
Tài liệu tham khảo
Moxey PW, Gogalniceanu P, Hinchliffe RJ, Loftus IM, Jones KJ, Thompson MM, Holt PJ. Lower extremity amputations–a review of global variability in incidence. Diabet Med. 2011;28(10):1144–53. https://doi.org/10.1111/j.1464-5491.2011.03279. (x PMID: 21388445).
Spraul M, Schönbach AM, Mühlhauser I, Berger M. Amputationen und Mortalität bei älteren, insulinpflichtigen Patienten mit Typ-2-Diabetes [Amputations and mortality in elderly insulin-treated patients with type 2 diabetes]. Zentralbl Chir. 1999;124(6):501–7 (German. PMID: 10436507).
Van Damme H, Limet R. Amputation in diabetic patients. Clin Podiatr Med Surg. 2007;24(3):569–82. https://doi.org/10.1016/j.cpm.2007.03.007. (PMID: 17613392).
Li M. Guidelines and standards for comprehensive clinical diagnosis and interventional treatment for diabetic foot in China (Issue 7.0). J Interv Med. 2021;4(3):117–29. https://doi.org/10.1016/j.jimed.2021.07.003. PMID: 34805959; PMCID: PMC8562298.
Nather A, Bee CS, Huak CY, Chew JL, Lin CB, Neo S, Sim EY. Epidemiology of diabetic foot problems and predictive factors for limb loss. J Diabetes Complications. 2008;22(2):77–82. https://doi.org/10.1016/j.jdiacomp.2007.04.004. (PMID: 18280436).
Hamann H, Cyba-Altunbay S. Bestimmung der Amputationshöhe [Determining the amputation level]. Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir. 1989:627-30. German. PMID: 2577609.
Nelson MT, Greenblatt DY, Soma G, Rajimanickam V, Greenberg CC, Kent KC. Preoperative factors predict mortality after major lower-extremity amputation. Surgery. 2012;152(4):685–94. https://doi.org/10.1016/j.surg.2012.07.017. (discussion 694-6 PMID: 23021137).
Endoh S, Yamana H, Nakahara Y, Matsui H, Fushimi K, Yasunaga H, Haga N. Risk Factors for In-hospital Mortality and Reamputation Following Lower Limb Amputation. Prog Rehabil Med. 2017;26(2):20170015. https://doi.org/10.2490/prm.20170015. (PMID:32789222;PMCID:PMC7365198).
Rosen N, Gigi R, Haim A, Salai M, Chechik O. Mortality and reoperations following lower limb amputations. Isr Med Assoc J. 2014;16(2):83–7 (PMID: 24645225).
Huang YQ, Gou R, Diao YS, Yin QH, Fan WX, Liang YP, Chen Y, Wu M, Zang L, Li L, Zang J, Cheng L, Fu P, Liu F. Charlson comorbidity index helps predict the risk of mortality for patients with type 2 diabetic nephropathy. J Zhejiang Univ Sci B. 2014;15(1):58–66. https://doi.org/10.1631/jzus.B1300109. (PMID:24390745;PMCID:PMC3891119).
Novotny V, Froehner M, Koch R, Zastrow S, Heberling U, Leike S, Hübler M, Wirth MP. Age, American Society of Anesthesiologists physical status classification and Charlson score are independent predictors of 90-day mortality after radical cystectomy. World J Urol. 2016;34(8):1123–9. https://doi.org/10.1007/s00345-015-1744-8. (Epub 2015 Dec 11 PMID: 26658887).
Lyu YB, Zhou JH, Duan J, Wang JN, Shi WY, Yin ZX, Shi WH, Mao C, Shi XM. Association of plasma albumin and hypersensitive C-reactive protein with 5-year all-cause mortality among Chinese older adults aged 65 and older from 8 longevity areas in China. Zhonghua Yu Fang Yi Xue Za Zhi. 2019;53(6):590–6. https://doi.org/10.3760/cma.j.issn.0253-9624.2019.06.010. (Chinese PMID: 31177756).
Li Y, Li L, Zhang L, Li W. Relationships between Serum Albumin and Urea Level and the Clinical Pathological Characteristics and Survival Time in Patients with Lung Cancer. Zhongguo Fei Ai Za Zhi. 2017;20(3):175–86 (Chinese. PMID: 28302220; PMCID: PMC5973299).
Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2000;35(3):469–76. https://doi.org/10.1016/s0272-6386(00)70200-9. (PMID: 10692273).
Mahmoodpoor A, Hamishehkar H, Shadvar K, Beigmohammadi M, Iranpour A, Sanaie S. Relationship between glycated hemoglobin, Intensive Care Unit admission blood sugar and glucose control with ICU mortality in critically ill patients. Indian J Crit Care Med. 2016;20(2):67–71. https://doi.org/10.4103/0972-5229.175938. (PMID:27076705;PMCID:PMC4810935).
Lou R, Jiang L, Zhu B. Effect of glycemic gap upon mortality in critically ill patients with diabetes. J Diabetes Investig. 2021;12(12):2212–20. https://doi.org/10.1111/jdi.13606. (Epub 2021 Aug 3. PMID: 34075715; PMCID: PMC8668057).